Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-24 @ 5:49 PM
NCT ID:
NCT00526968
Eligibility Criteria:
Inclusion Criteria:
* Healthy Male volunteers
* Body Mass Index between 19 and 29
Exclusion Criteria:
* Subjects who received any prescribed medication within 5 half lives or 14 days of the first dose administration whichever is the longer
* Subjects who have received any prescribed CNS medication or any medication known to chronically alter drug absorption or elimination processes within 30 days of first dose administration
* Participation in a clinical trial of an investigational drug within the past 4 months or of a marketed drug within the past 3 months
* History of allergy to NMDA antagonists or other clinically significant drug allergy
* Supine blood pressure and heart rate of higher than 140/90 mmHg and 90 bpm respectively or lower than 80/40 mmHg and 40 bpm
* Consumption of more than 21 units of alcohol per week or history of alcoholism or drug/chemical abuse
* Smokers of more than 5 cigarettes or equivalent per day
* Subjects who cannot complete the neuropsychological test battery
* Any clinically significant health deficit
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
55 Years
Study:
NCT00526968
Study Brief:
Protocol Section:
NCT00526968